Himanshu Nagar
@himanshunagarmd.bsky.social
Director of Genitourinary Program in Radiation Oncology at @mskcancercenter.bsky.social
Runs to Fundraise for Prostate Cancer Awareness and Research
Runs to Fundraise for Prostate Cancer Awareness and Research
Reposted by Himanshu Nagar
Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️
The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know
It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.
www.mskcc.org
September 24, 2025 at 5:38 PM
Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From #SBRT to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with #prostatecancer. ⬇️
Reposted by Himanshu Nagar
NRG-GU015, the "ARCHER" study, recently activated! We interviewed study PI, Scott Delacroix, and co-PI @himanshunagarmd.bsky.social on this phase 3 study of adaptive radiation and chemotherapy for muscle invasive #bladdercancer. Watch the full interview here: youtu.be/qCc-htw39to
August 21, 2025 at 3:51 PM
NRG-GU015, the "ARCHER" study, recently activated! We interviewed study PI, Scott Delacroix, and co-PI @himanshunagarmd.bsky.social on this phase 3 study of adaptive radiation and chemotherapy for muscle invasive #bladdercancer. Watch the full interview here: youtu.be/qCc-htw39to
Reposted by Himanshu Nagar
Enrollment in now open in the phase 3 ARCHER trial, which is assessing the safety and efficacy of a shorter duration of radiation therapy in patients with muscle invasive bladder cancer. www.urologytimes.com/view/archer-...
ARCHER trial opens enrollment to assess shorter duration of radiation therapy for MIBC
The ARCHER trial is seeking to determine whether ultra-hypofractionated radiotherapy is non-inferior to hypofractionated radiotherapy in terms of bladder-intact event-free survival.
www.urologytimes.com
August 14, 2025 at 7:35 PM
Enrollment in now open in the phase 3 ARCHER trial, which is assessing the safety and efficacy of a shorter duration of radiation therapy in patients with muscle invasive bladder cancer. www.urologytimes.com/view/archer-...
Reposted by Himanshu Nagar
PRESS RELEASE: NRG Oncology Opens New “ARCHER” Clinical Trial (NRG-GU015) Testing a Shorter Treatment Duration of Radiation Therapy for Muscle Invasive Bladder Cancer - Read more: ow.ly/6lyF50WG0GN
@himanshunagarmd.bsky.social
@mskcancercenter.bsky.social
@himanshunagarmd.bsky.social
@mskcancercenter.bsky.social
August 14, 2025 at 2:21 PM
PRESS RELEASE: NRG Oncology Opens New “ARCHER” Clinical Trial (NRG-GU015) Testing a Shorter Treatment Duration of Radiation Therapy for Muscle Invasive Bladder Cancer - Read more: ow.ly/6lyF50WG0GN
@himanshunagarmd.bsky.social
@mskcancercenter.bsky.social
@himanshunagarmd.bsky.social
@mskcancercenter.bsky.social
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution @mskcancercenter.bsky.social @weillcornell.bsky.social
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at ...
Some patients undergoing prostatectomy develop biochemical recurrence or have persistently detectable prostate-specific antigen level. Salvage radioth…
www.sciencedirect.com
June 10, 2025 at 4:46 AM
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution @mskcancercenter.bsky.social @weillcornell.bsky.social
Reposted by Himanshu Nagar
TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial
Optimal management of oligoprogressive prostate cancer whilst on androgen receptor pathway inhibitors (ARPi) is not known. The **** trial tests the ro…
www.sciencedirect.com
March 10, 2025 at 8:43 AM
TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Himanshu Nagar
Last week, the 19th MR-Linac Consortium meeting convened in Singapore. It was great to see such high energy and strong global community come together to share insights on new clinical and technical innovations. Special thanks to all the presenters and attendees, see you next time! #MRgRT #innovation
November 19, 2024 at 3:45 PM
Last week, the 19th MR-Linac Consortium meeting convened in Singapore. It was great to see such high energy and strong global community come together to share insights on new clinical and technical innovations. Special thanks to all the presenters and attendees, see you next time! #MRgRT #innovation
Reposted by Himanshu Nagar
PEACE-1 trial of prostate radiotherapy in mHSPC. Improvement in rPFS when used in addition to ADT and abiraterone. Medsky. Oncsky.
November 25, 2024 at 2:20 PM
PEACE-1 trial of prostate radiotherapy in mHSPC. Improvement in rPFS when used in addition to ADT and abiraterone. Medsky. Oncsky.
Reposted by Himanshu Nagar
Proud of my sister. Calm, deliberative, and forward focused. @blandro.bsky.social
youtube.com/watch?v=w2ft...
youtube.com/watch?v=w2ft...
youtube.com
November 24, 2024 at 1:33 AM
Proud of my sister. Calm, deliberative, and forward focused. @blandro.bsky.social
youtube.com/watch?v=w2ft...
youtube.com/watch?v=w2ft...
Reposted by Himanshu Nagar
Free learning opportunity! Try your ✋at outlining the prostate and urethra on MRI. See how your answer overlays on expert panel's consensus contours.
#radonc #radiology #nucmed #urology welcome. Trainees and attendings. Generalists and specialists.
#radonc #radiology #nucmed #urology welcome. Trainees and attendings. Generalists and specialists.
🚨🚨Prostate and UREthra on MRI (PURE-MRI):
Try to contour (outline) the prostate and urethra on MRI for 1 patient
After everyone is done, we will enable the “answer key”
And you help us learn how to help doctors and AI do better
Sign up here: redcap.link/PURE-MRI
🙏🏼
Try to contour (outline) the prostate and urethra on MRI for 1 patient
After everyone is done, we will enable the “answer key”
And you help us learn how to help doctors and AI do better
Sign up here: redcap.link/PURE-MRI
🙏🏼
November 22, 2024 at 11:30 PM
Free learning opportunity! Try your ✋at outlining the prostate and urethra on MRI. See how your answer overlays on expert panel's consensus contours.
#radonc #radiology #nucmed #urology welcome. Trainees and attendings. Generalists and specialists.
#radonc #radiology #nucmed #urology welcome. Trainees and attendings. Generalists and specialists.
Reposted by Himanshu Nagar
MRI Vs CT Guidance for Stereotactic Body Radiotherapy in #ProstateCancer
MIRAGE trial out on European Urology
Results suggest that MRI-guided SBRT offers long-term benefits in reducing toxic effects by allowing for more aggressive margin reduction in treatment planning.
https://buff.ly/4fA8VmA
MIRAGE trial out on European Urology
Results suggest that MRI-guided SBRT offers long-term benefits in reducing toxic effects by allowing for more aggressive margin reduction in treatment planning.
https://buff.ly/4fA8VmA
November 16, 2024 at 1:58 PM
MRI Vs CT Guidance for Stereotactic Body Radiotherapy in #ProstateCancer
MIRAGE trial out on European Urology
Results suggest that MRI-guided SBRT offers long-term benefits in reducing toxic effects by allowing for more aggressive margin reduction in treatment planning.
https://buff.ly/4fA8VmA
MIRAGE trial out on European Urology
Results suggest that MRI-guided SBRT offers long-term benefits in reducing toxic effects by allowing for more aggressive margin reduction in treatment planning.
https://buff.ly/4fA8VmA
Fill out an application to run the 2025 #NYCMarathon with
#Fred'sTeam to raise money for cancer research at #MemorialSloanKetteringCancerCenter.
Run TCS New York City Marathon for Cancer Research | Fred's Team
Find out how you can run in the next TCS New York City Marathon as a Fred's Team member and help raise money for pioneering cancer research at MSK.
www.fredsteam.org
November 15, 2024 at 3:12 PM
Fill out an application to run the 2025 #NYCMarathon with
#Fred'sTeam to raise money for cancer research at #MemorialSloanKetteringCancerCenter.